We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Enhanced, Rapid Target Identification by NGS for Vaccine Development


Enhanced, Rapid Target Identification by NGS for Vaccine Development

Who's speaking at this Webinar?

Cris Kinross
Thermo Fisher Scientific

Next-generation sequencing (NGS) is the primary technology used to identify genomic targets. Enhanced options for NGS now make it possible to identify multiple potentially pathogenic strains of a disease and understand the rate of evolution quickly, with improved precision. These tools are paramount to thwart the current global pandemic, to identify targets for vaccine development.

Watch this webinar to learn about two complementary sequencing methods and how they can:

  • Provide the entire genomic assembly
  • Offer an improvement over outdated transposomic methods
  • Provide gene expression insights into host-pathogen interactions


Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free